Kaifeng Guo

812 total citations
42 papers, 599 citations indexed

About

Kaifeng Guo is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kaifeng Guo has authored 42 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kaifeng Guo's work include Chronic Kidney Disease and Diabetes (8 papers), Lipid metabolism and disorders (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Kaifeng Guo is often cited by papers focused on Chronic Kidney Disease and Diabetes (8 papers), Lipid metabolism and disorders (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Kaifeng Guo collaborates with scholars based in China, United States and New Zealand. Kaifeng Guo's co-authors include Haibing Chen, Junxi Lu, Weiping Jia, Yuqian Bao, Haoyong Yu, Mian Wu, Yan Huang, Pan Pan, Yoshinori Nio and Ming Dong and has published in prestigious journals such as PLoS ONE, Scientific Reports and IEEE Access.

In The Last Decade

Kaifeng Guo

36 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaifeng Guo China 14 162 143 142 130 121 42 599
Hongjie Wang China 15 67 0.4× 140 1.0× 146 1.0× 174 1.3× 57 0.5× 31 823
Jie Wen China 17 233 1.4× 117 0.8× 245 1.7× 236 1.8× 147 1.2× 37 843
Tomoo Furumoto Japan 17 189 1.2× 442 3.1× 170 1.2× 126 1.0× 74 0.6× 34 888
Wen Wen China 15 59 0.4× 100 0.7× 235 1.7× 110 0.8× 38 0.3× 44 730
Marcel Roos Germany 16 76 0.5× 142 1.0× 263 1.9× 87 0.7× 278 2.3× 38 808
Masayoshi Yoshii Japan 17 192 1.2× 337 2.4× 226 1.6× 54 0.4× 95 0.8× 30 764
Min He China 19 407 2.5× 176 1.2× 243 1.7× 231 1.8× 127 1.0× 63 1.0k
Yutong Zou China 13 124 0.8× 46 0.3× 103 0.7× 76 0.6× 176 1.5× 38 526
Engın Güney Türkiye 16 294 1.8× 79 0.6× 78 0.5× 141 1.1× 68 0.6× 52 884
Masafumi Myoishi Japan 12 210 1.3× 284 2.0× 278 2.0× 131 1.0× 32 0.3× 16 928

Countries citing papers authored by Kaifeng Guo

Since Specialization
Citations

This map shows the geographic impact of Kaifeng Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaifeng Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaifeng Guo more than expected).

Fields of papers citing papers by Kaifeng Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaifeng Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaifeng Guo. The network helps show where Kaifeng Guo may publish in the future.

Co-authorship network of co-authors of Kaifeng Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Kaifeng Guo. A scholar is included among the top collaborators of Kaifeng Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaifeng Guo. Kaifeng Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Kaifeng, Yali Han, Shuang Liu, et al.. (2024). Prevalence of and trends in hyperuricemia by race and ethnicity among US adolescents, 1999–2018. Arthritis Research & Therapy. 26(1). 193–193. 4 indexed citations
2.
Li, Xuezheng, et al.. (2024). Efficacy and safety of hyperbaric oxygen therapy in acute ischaemic stroke: a systematic review and meta-analysis. BMC Neurology. 24(1). 55–55. 5 indexed citations
3.
Guo, Kaifeng & Haoling Xie. (2024). Deep learning in finance assessing twitter sentiment impact and prediction on stocks. PeerJ Computer Science. 10. e2018–e2018. 2 indexed citations
4.
5.
Guo, Kaifeng, et al.. (2024). Urinary PKM2, a marker predicating acute kidney injury in patients with sepsis. International Urology and Nephrology. 56(9). 3039–3045. 2 indexed citations
6.
Li, Xuezheng, et al.. (2023). Systematic review and meta-analysis of the efficacy and safety of electroacupuncture for poststroke dysphagia. Frontiers in Neurology. 14. 1270624–1270624. 2 indexed citations
7.
Li, Xuezheng, et al.. (2023). Electroacupuncture at HT5 + GB20 promotes brain remodeling and significantly improves swallowing function in patients with stroke. Frontiers in Neuroscience. 17. 1274419–1274419. 5 indexed citations
8.
Guo, Kaifeng, et al.. (2023). Graph convolutional network and self-attentive for sequential recommendation. PeerJ Computer Science. 9. e1701–e1701. 1 indexed citations
9.
Li, Xuezheng, et al.. (2023). Electroacupuncture at HT5 + GB20 produces stronger activation effect on swallowing cortex and muscle than single points. Heliyon. 9(11). e21922–e21922. 1 indexed citations
10.
11.
Guo, Kaifeng, et al.. (2023). An Efficient DOA Estimation Method for FH Signals Based on MSST. 100–105.
12.
Guo, Kaifeng, et al.. (2022). Prevalence and Risk Factors for Peripheral Neuropathy in Chinese Patients With Gout. Frontiers in Neurology. 13. 789631–789631. 1 indexed citations
13.
Wu, Mian, Lu Li, Kaifeng Guo, Junxi Lu, & Haibing Chen. (2022). Vitamin D protects against high glucose-induced pancreatic β-cell dysfunction via AMPK-NLRP3 inflammasome pathway. Molecular and Cellular Endocrinology. 547. 111596–111596. 31 indexed citations
14.
Guo, Kaifeng, et al.. (2020). Hyposialylated angiopoietin-like-4 induces apoptosis of podocytes via β1 Integrin/FAK signaling in diabetic nephropathy. Molecular and Cellular Endocrinology. 505. 110730–110730. 13 indexed citations
15.
Guo, Kaifeng, Lei Zhang, Junxi Lu, et al.. (2016). Prevalence of chronic kidney disease and associated factors in Chinese individuals with type 2 diabetes: Cross-sectional study. Journal of Diabetes and its Complications. 30(5). 803–810. 58 indexed citations
16.
Zhang, Lei, Kaifeng Guo, Junxi Lu, et al.. (2016). Nonalcoholic Fatty Liver Disease is Associated with Increased Carotid Intima-Media Thickness in Type 1 Diabetic Patients. Scientific Reports. 6(1). 26805–26805. 19 indexed citations
17.
Guo, Kaifeng, Lei Zhang, Junxi Lu, et al.. (2016). Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes. Journal of Diabetes and its Complications. 31(1). 80–85. 25 indexed citations
18.
Chen, Haibing, Zhi Zheng, Yan Huang, et al.. (2012). A Microalbuminuria Threshold to Predict the Risk for the Development of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients. PLoS ONE. 7(5). e36718–e36718. 40 indexed citations
19.
Huang, Yan, Haoyong Yu, Junxi Lu, et al.. (2012). Oral Supplementation with Cholecalciferol 800 IU Ameliorates Albuminuria in Chinese Type 2 Diabetic Patients with Nephropathy. PLoS ONE. 7(11). e50510–e50510. 45 indexed citations
20.
Dong, Ming, et al.. (1999). Epidermal growth factor and its receptor as prognostic indicators in Chinese patients with pancreatic cancer.. PubMed. 18(6B). 4613–9. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongjie Wang Breakdown of academic impact, for papers by Jie Wen Breakdown of academic impact, for papers by Tomoo Furumoto Breakdown of academic impact, for papers by Wen Wen Breakdown of academic impact, for papers by Marcel Roos Breakdown of academic impact, for papers by Masayoshi Yoshii Breakdown of academic impact, for papers by Min He Breakdown of academic impact, for papers by Yutong Zou Breakdown of academic impact, for papers by Engın Güney Breakdown of academic impact, for papers by Masafumi Myoishi
Rankless by CCL
2026